SCHEMBL15063121

SCHEMBL15063121

COc1ccc(CCC(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)cc1OC

nearest known ligand 0.74

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.74
GAA P10253 1/20 0.74
KMT2A Q03164 9/20 0.63
MEN1 O00255 7/20 0.61
ALDH1A1 P00352 5/20 0.61
LMNA P02545 2/20 0.61
ACP1 P24666 1/20 0.58
DYRK1A Q13627 1/20 0.58
NOD2 Q9HC29 1/20 0.57
HTT P42858 2/20 0.55
POLB P06746 2/20 0.54
STAT1 P42224 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15063122 0.94 MAPT (0.66) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL15083819 0.94 MAPT (0.65) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL18700065 0.93 MAPT (0.64) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL15489026 0.93 MAPT (0.64) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL18905633 0.93 MAPT (0.65) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL15112845 0.90 KMT2A (0.66) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL18700000 0.90 MAPT (0.61) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL18700002 0.89 MAPT (0.66) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL15489025 0.87 MAPT (0.63) MAPTGAAKMT2AMEN1ALDH1A1
SCHEMBL18905634 0.87 MAPT (0.60) MAPTGAAKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3431584-B1 METHODS FOR FREEZING AN AGGREGATE OF PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES UNIV KYOTO (JP) 2023-06-28 EP disclosed
EP-3150705-B1 METHOD FOR INDUCING MYOCARDIAL DIFFERENTIATION OF PLURIPOTENT STEM CELLS USING LOW-MOLECULAR COMPOUND UNIV KYOTO (JP) 2019-05-15 EP disclosed
EP-2966166-B1 PROMOTER OF DIFFERENTIATION OF PLURIPOTENT STEM CELL INTO MYOCARDIUM, WHICH COMPRISES EGF RECEPTOR INHIBITOR UNIV KYOTO (JP) 2019-04-03 EP disclosed
EP-3431584-A1 FREEZING METHOD FOR AGGREGATES OF PLURIPOTENT STEM CELL-DERIVED MYOCARDIAL CELLS Kyoto University (JP) 2019-01-23 EP disclosed
EP-2808383-B1 METHOD FOR INDUCING CARDIAC DIFFERENTIATION OF PLURIPOTENT STEM CELL UNIV KYOTO (JP) 2018-07-25 EP disclosed
EP-2808383-B1 METHOD FOR INDUCING CARDIAC DIFFERENTIATION OF PLURIPOTENT STEM CELL UNIV KYOTO (JP) 2018-07-25 EP disclosed
EP-2610249-B1 PLURIPOTENT STEM CELL CARDIOMYOCYTE DIFFERENTIATION-PROMOTING AGENT UNIV KYOTO (JP) 2017-10-11 EP disclosed
EP-2610249-B1 PLURIPOTENT STEM CELL CARDIOMYOCYTE DIFFERENTIATION-PROMOTING AGENT UNIV KYOTO (JP) 2017-10-11 EP disclosed
US-20170152485-A1 Method for Inducing Cardiac Differentiation of Pluripotent Stem Cell with Low-Molecular Compounds KYOTO UNIVERSITY (JP) 2017-06-01 US disclosed
US-20170152485-A1 Method for Inducing Cardiac Differentiation of Pluripotent Stem Cell with Low-Molecular Compounds KYOTO UNIVERSITY (JP) 2017-06-01 US disclosed
EP-2808383-A1 METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELL INTO CARDIAC MUSCLE Kyoto University (JP) 2014-12-03 EP disclosed
US-20140127807-A1 Method for Promoting Differentiation of Pluripotent Stem Cells into Cardiac Muscle Cells KYOTO UNIVERSITY (JP) 2014-05-08 US disclosed
US-8658425-B2 Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells KYOTO UNIVERSITY (JP) 2014-02-25 US disclosed
US-8658425-B2 Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells KYOTO UNIVERSITY (JP) 2014-02-25 US disclosed
US-8658425-B2 Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells KYOTO UNIVERSITY (JP) 2014-02-25 US disclosed
US-20130183753-A1 METHOD FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIAC MUSCLE CELLS KYOTO UNIVERSITY (JP) 2013-07-18 US disclosed
US-20130183753-A1 METHOD FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIAC MUSCLE CELLS KYOTO UNIVERSITY (JP) 2013-07-18 US disclosed
US-20130183753-A1 METHOD FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIAC MUSCLE CELLS KYOTO UNIVERSITY (JP) 2013-07-18 US disclosed
EP-2610249-A1 PLURIPOTENT STEM CELL CARDIOMYOCYTE DIFFERENTIATION-PROMOTING AGENT Kyoto University (JP) 2013-07-03 EP disclosed
EP-2610249-A1 PLURIPOTENT STEM CELL CARDIOMYOCYTE DIFFERENTIATION-PROMOTING AGENT Kyoto University (JP) 2013-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130183753-A1 METHOD FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIAC MUSCLE CELLS TNNI3, MYLK2, TNNT2 MAPT 4471/4885GAA 2914/4885KMT2A 3036/4885
US-20140127807-A1 Method for Promoting Differentiation of Pluripotent Stem Cells into Cardiac Muscle Cells TNNI3, MYLK2, TNNT2 MAPT 4439/4885GAA 2721/4885KMT2A 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.